Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02645175 | Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue | terminated | Phase 2 | 3 | Meriyana Bio Inc.INDUSTRY | 0 | Oct 21, 2016 | clinicaltrials |
| NCT01194869 | Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer | terminated | Phase 2 | 25 | Emory UniversityOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT01188915 |
| Personalised Program for Women Treated for Hodgkin Disease(PROPER) |
| terminated |
| N/A |
| 51 |
| Institut Paoli-CalmettesOTHER |
| 1 |
| Oct 14, 2016 |
| clinicaltrials |
| NCT01910844 | Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes(META2) | terminated | Phase 2 | 3 | Centre Jean PerrinOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT01498588 | Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer | terminated | Phase 2 | 7 | Emory UniversityOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT01032447 | Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program | terminated | — | 45 | Stanford UniversityOTHER | 1 | Sep 28, 2016 | clinicaltrials |
| NCT01723124 | Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up | terminated | N/A | 228 | Mayo ClinicOTHER | 1 | Sep 21, 2016 | clinicaltrials |
| NCT00603408 | Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer | terminated | Phase 2 | 5 | Washington University School of MedicineOTHER | 1 | Aug 19, 2016 | clinicaltrials |
| NCT01132664 | Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer | terminated | Phase 1 / Phase 2 | 72 | Novartis PharmaceuticalsINDUSTRY | 6 | Aug 17, 2016 | clinicaltrials |
| NCT01653366 | Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway | terminated | N/A | 4 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 16, 2016 | clinicaltrials |
| NCT01836640 | Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer | terminated | — | 9 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 16, 2016 | clinicaltrials |
| NCT00805597 | Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes | terminated | Phase 3 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT01938651 | Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer | terminated | N/A | 3 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT01568346 | Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy | terminated | Phase 3 | 9 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT00427427 | Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer | terminated | Phase 2 | 75 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT01528345 | Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer | terminated | Phase 2 | 97 | Novartis PharmaceuticalsINDUSTRY | 15 | Jul 11, 2016 | clinicaltrials |
| NCT01346579 | Biomarkers in Tissue Samples From Older Women With Breast Cancer | terminated | — | 505 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 4, 2016 | clinicaltrials |
| NCT00933088 | Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer | terminated | — | 43 | NYU Langone HealthOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01339000 | Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | terminated | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01805908 | Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC)(PETRA) | terminated | Phase 1 | 3 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 6, 2016 | clinicaltrials |
| NCT00794989 | Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer | terminated | N/A | 20 | Roswell Park Cancer InstituteOTHER | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00429403 | Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
| NCT00567879 | A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab | terminated | Phase 1 / Phase 2 | 56 | Novartis PharmaceuticalsINDUSTRY | 6 | May 9, 2016 | clinicaltrials |
| NCT01934114 | NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo | terminated | — | 8 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT00346229 | Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer | terminated | Phase 1 | 29 | Duke UniversityOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT01069796 | Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 64 | ARCAGY/ GINECO GROUPOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT01662726 | A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth(IPET) | terminated | Phase 2 | 13 | Imperial College LondonOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00546364 | Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer(IXTEND) | terminated | Phase 2 | 62 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00634088 | Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer | terminated | Phase 1 | 13 | R-PharmINDUSTRY | 3 | Mar 10, 2016 | clinicaltrials |
| NCT00131612 | An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment | terminated | — | 120 | AHS Cancer Control AlbertaOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT00773474 | Lonafarnib in Metastatic Breast Cancer | terminated | Phase 2 | 29 | George SledgeOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | terminated | Phase 2 | 7 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01796977 | Using A Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy(NSM) | terminated | N/A | 27 | Halyard HealthINDUSTRY | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01029925 | Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL) | terminated | Phase 2 | 7 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 12, 2016 | clinicaltrials |
| NCT01534455 | Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA) | terminated | Phase 2 | 43 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT01773460 | Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane(Evelyn) | terminated | Phase 3 | 3 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT00998738 | Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer | terminated | Phase 3 | 1 | Mayo ClinicOTHER | 1 | Feb 4, 2016 | clinicaltrials |
| NCT01890824 | Fat Metabolism Following Chemotherapy in Breast Cancer | terminated | — | 5 | Texas A&M UniversityOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT02131506 | A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer(CAELYX) | terminated | Phase 1 | 11 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT00824733 | Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 6 | Bhuvaneswari RamaswamyOTHER | 1 | Jan 14, 2016 | clinicaltrials |
| NCT00595023 | GeneSearch Breast Lymph Node (BLN) Assay Timing Study | terminated | — | 233 | Janssen Diagnostics, LLCINDUSTRY | 1 | Jan 12, 2016 | clinicaltrials |
| NCT00595296 | GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study | terminated | — | 461 | Janssen Diagnostics, LLCINDUSTRY | 1 | Jan 12, 2016 | clinicaltrials |
| NCT01919229 | A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)(MONALEESA-1) | terminated | Phase 2 | 14 | Novartis PharmaceuticalsINDUSTRY | 3 | Jan 1, 2016 | clinicaltrials |
| NCT01563588 | Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After Chemotherapy | terminated | N/A | 251 | Centre Jean PerrinOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT02252991 | Adaptated Physical Activity in Cancerology(APACAN) | terminated | N/A | 3 | Centre Jean PerrinOTHER | 0 | Dec 28, 2015 | clinicaltrials |
| NCT00305643 | Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer | terminated | Phase 3 | 11 | M.D. Anderson Cancer CenterOTHER | 2 | Dec 24, 2015 | clinicaltrials |
| NCT01249157 | Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast | terminated | N/A | 6 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT01532232 | Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix) | terminated | — | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 23, 2015 | clinicaltrials |
| NCT00347438 | Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer | terminated | Phase 2 | 18 | University of ChicagoOTHER | 2 | Dec 14, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Oct 21, 2016source: clinicaltrials